Ranbaxy-manufactured drugs are seen at an Indian chemist shop in New Delhi on May 14, 2013. Shares in India's biggest drug maker Ranbaxy were trading up after US authorities imposed a USD500 million fine to settle a lengthy lawsuit over the sale of adulterated drugs. The case -- the largest ever drug-safety settlement with a drug manufacturer -- brings to conclusion eight years of criminal and civil investigations into the Indian firm, which is majority-owned by Japan's Daiichi Sankyo.
FIRSTPOST. ARTICLES View all
FROM THE WEB.